Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) has received an average rating of “Moderate Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price […]
